Minakem Generic APIs Minakem Generic APIs

X

Find the latest Drugs in Development and Pipeline Prospector News of NEC OncoImmunity.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
NEC OncoImmunity
Norway Flag
Country
Country
Norway
Address
Address
Oslo Cancer Cluster, Innovation Park, Ullernchausséen 64, 0379, Oslo, Norway
Telephone
Telephone
4790015242

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Under the agreement, NOI will acquire VAXIMM’s neoantigen vaccine-related patents including VXM01, which is being developed for the treatment of glioblastoma, license the requisite manufacturing patents, and will take over existing contracts with collaborators and partners.


Lead Product(s): Necvax Neo 1

Therapeutic Area: Oncology Product Name: Necvax Neo 1

Highest Development Status: PreclinicalProduct Type: Vaccine

Recipient: Vaximm AG

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition March 08, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY